285 related articles for article (PubMed ID: 20664940)
1. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles.
Minoo P; Zlobec I; Peterson M; Terracciano L; Lugli A
Int J Oncol; 2010 Sep; 37(3):707-18. PubMed ID: 20664940
[TBL] [Abstract][Full Text] [Related]
2. A comparison of colon and rectal somatic DNA alterations.
Slattery ML; Curtin K; Wolff RK; Boucher KM; Sweeney C; Edwards S; Caan BJ; Samowitz W
Dis Colon Rectum; 2009 Jul; 52(7):1304-11. PubMed ID: 19571709
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of oncogenesis in colon versus rectal cancer.
Kapiteijn E; Liefers GJ; Los LC; Kranenbarg EK; Hermans J; Tollenaar RA; Moriya Y; van de Velde CJ; van Krieken JH
J Pathol; 2001 Sep; 195(2):171-8. PubMed ID: 11592095
[TBL] [Abstract][Full Text] [Related]
4. Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry.
Gawlick U; Lu KC; Douthit MA; Diggs BS; Schuff KG; Herzig DO; Tsikitis VL
Am J Surg; 2013 May; 205(5):608-12; discussion 612. PubMed ID: 23592171
[TBL] [Abstract][Full Text] [Related]
5. Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy.
Maus MK; Hanna DL; Stephens CL; Astrow SH; Yang D; Grimminger PP; Loupakis F; Hsiang JH; Zeger G; Wakatsuki T; Barzi A; Lenz HJ
Pharmacogenomics J; 2015 Aug; 15(4):354-62. PubMed ID: 25532759
[TBL] [Abstract][Full Text] [Related]
6. [Insights on colorectal carcinoma based on the biological differences between left-sided and right- sided colon cancers].
Xu JM
Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):397-400. PubMed ID: 27188617
[TBL] [Abstract][Full Text] [Related]
7. Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma.
Benedix F; Meyer F; Kube R; Kropf S; Kuester D; Lippert H; Roessner A; Krüger S
Pathol Res Pract; 2012 Oct; 208(10):592-7. PubMed ID: 22898351
[TBL] [Abstract][Full Text] [Related]
8. Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer.
Gao XH; Yu GY; Gong HF; Liu LJ; Xu Y; Hao LQ; Liu P; Liu ZH; Bai CG; Zhang W
Sci Rep; 2017 Aug; 7(1):7882. PubMed ID: 28801584
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A
Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A
J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972
[TBL] [Abstract][Full Text] [Related]
11. Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: analysis of clinicopathological and molecular features and prognoses.
Kim YH; Min BH; Kim SJ; Choi HK; Kim KM; Chun HK; Lee H; Kim JY; Chang DK; Son HJ; Rhee PL; Rhee JC; Kim JJ
Ann Surg Oncol; 2010 May; 17(5):1435-41. PubMed ID: 20049642
[TBL] [Abstract][Full Text] [Related]
12. Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas.
Kalady MF; Sanchez JA; Manilich E; Hammel J; Casey G; Church JM
Dis Colon Rectum; 2009 Jun; 52(6):1039-45. PubMed ID: 19581844
[TBL] [Abstract][Full Text] [Related]
13. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum.
Wiland HO; Shadrach B; Allende D; Carver P; Goldblum JR; Liu X; Patil DT; Rybicki LA; Pai RK
Am J Surg Pathol; 2014 Sep; 38(9):1290-7. PubMed ID: 25127095
[TBL] [Abstract][Full Text] [Related]
14. KRAS Mutant Status, p16 and β-catenin Expression May Predict Local Recurrence in Patients Who Underwent Transanal Endoscopic Microsurgery (TEMS) for Stage I Rectal Cancer.
Sideris M; Moorhead J; Diaz-Cano S; Bjarnason I; Haji A; Papagrigoriadis S
Anticancer Res; 2016 Oct; 36(10):5315-5324. PubMed ID: 27798894
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
[TBL] [Abstract][Full Text] [Related]
16. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.
Koinuma K; Shitoh K; Miyakura Y; Furukawa T; Yamashita Y; Ota J; Ohki R; Choi YL; Wada T; Konishi F; Nagai H; Mano H
Int J Cancer; 2004 Jan; 108(2):237-42. PubMed ID: 14639609
[TBL] [Abstract][Full Text] [Related]
17. Mucinous carcinomas of the colon and rectum show higher rates of microsatellite instability and lower rates of chromosomal instability: a study matched for T classification and tumor location.
Kazama Y; Watanabe T; Kanazawa T; Tada T; Tanaka J; Nagawa H
Cancer; 2005 May; 103(10):2023-9. PubMed ID: 15812832
[TBL] [Abstract][Full Text] [Related]
18. HER2 status in patients with residual rectal cancer after preoperative chemoradiotherapy: the relationship with molecular results and clinicopathologic features.
Park JS; Yoon G; Kim HJ; Park SY; Choi GS; Kang MK; Kim JG; Jang JS; Seo AN
Virchows Arch; 2018 Oct; 473(4):413-423. PubMed ID: 30056472
[TBL] [Abstract][Full Text] [Related]
19. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.
Hong SP; Min BS; Kim TI; Cheon JH; Kim NK; Kim H; Kim WH
Eur J Cancer; 2012 May; 48(8):1235-43. PubMed ID: 22071131
[TBL] [Abstract][Full Text] [Related]
20. Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival.
Mima K; Nowak JA; Qian ZR; Cao Y; Song M; Masugi Y; Shi Y; da Silva A; Gu M; Li W; Hamada T; Zhang X; Wu K; Meyerhardt JA; Baba H; Giovannucci EL; Chan AT; Fuchs CS; Ogino S; Nishihara R
Oncotarget; 2016 Aug; 7(34):55098-55109. PubMed ID: 27391152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]